Precision Value & Health Grows Communications Services in Europe
Company acquires Makara Health, who will work alongside Precision’s branded medical and scientific agency.
Precision Value & Health, a New York-based company that provides commercialization services that range from market intelligence platforms to value and access solutions, has acquired Makara Health, a healthcare communications agency located in the UK. The move—says Precision—will expand its European footprint and reinforce the company’s market growth position with its principal capabilities in the region.
The acquisition of Makara boosts Precision Value & Health’s ability to offer pharma clients in Europe culturally aligned programs, along with support to achieve their business objectives. The company has specializations in learning and development, medical and patient education, PR, and brand promotion. It will be working closely with PRECISIONscientia, an agency that delivers medical and scientific communications.
“Broadening the reach of our services in Europe is one of Precision Value & Health's focused strategies in order to extend our offering to more organizations and healthcare clinicians around the world,” comments Doug Fulling, president of Precision Value & Health.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.
